BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27872580)

  • 1. Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine
    Carlisle SM; Trainor PJ; Yin X; Doll MA; Stepp MW; States JC; Zhang X; Hein DW
    Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27872580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
    Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
    Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
    Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
    Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Arylamine
    Carlisle SM; Trainor PJ; Doll MA; Hein DW
    Front Pharmacol; 2021; 12():803254. PubMed ID: 35046826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable Isotope Tracing Reveals an Altered Fate of Glucose in
    Wise JTF; Yin X; Ma X; Zhang X; Hein DW
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
    Tiang JM; Butcher NJ; Minchin RF
    Cancer Med; 2015 Apr; 4(4):565-74. PubMed ID: 25627111
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Stepp MW; Salazar-González RA; Hong KU; Doll MA; Hein DW
    J Oncol; 2019; 2019():3860426. PubMed ID: 31531019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis.
    Doll MA; Ray AR; Salazar-González RA; Shah PP; Vega AA; Sears SM; Krueger AM; Hong KU; Beverly LJ; Hein DW
    Mol Carcinog; 2022 May; 61(5):481-493. PubMed ID: 35133049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells.
    Hong KU; Tagnedji AH; Doll MA; Walls KM; Hein DW
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5047-5060. PubMed ID: 36329350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylamine
    Salazar-González RA; Doll MA; Hein DW
    Front Pharmacol; 2022; 13():797469. PubMed ID: 35153780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A.
    Xu X; Li de la Sierra-Gallay I; Kubiak X; Duval R; Chaffotte AF; Dupret JM; Haouz A; Rodrigues-Lima F
    Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):266-73. PubMed ID: 25664736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human
    Hein DW; Doll MA; Habil MR
    Front Pharmacol; 2022; 13():821133. PubMed ID: 35281898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide.
    Atmane N; Dairou J; Paul A; Dupret JM; Rodrigues-Lima F
    J Biol Chem; 2003 Sep; 278(37):35086-92. PubMed ID: 12832400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for human arylamine N-acetyltransferase 1 in the methionine salvage pathway.
    Witham KL; Minchin RF; Butcher NJ
    Biochem Pharmacol; 2017 Feb; 125():93-100. PubMed ID: 27865712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis.
    Sinclair J; Sim E
    Biochem Pharmacol; 1997 Jan; 53(1):11-6. PubMed ID: 8960058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl coenzyme A kinetic studies on
    Habil MR; Doll MA; Hein DW
    Front Pharmacol; 2022; 13():931323. PubMed ID: 36386142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting Effects of Temperature on Human Arylamine
    Choudhury C; McAleese CE; Butcher NJ; Minchin RF
    Biochemistry; 2023 Jul; 62(14):2093-2097. PubMed ID: 37318062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition.
    Ragunathan N; Dairou J; Pluvinage B; Martins M; Petit E; Janel N; Dupret JM; Rodrigues-Lima F
    Mol Pharmacol; 2008 Jun; 73(6):1761-8. PubMed ID: 18310302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
    Laurieri N; Dairou J; Egleton JE; Stanley LA; Russell AJ; Dupret JM; Sim E; Rodrigues-Lima F
    PLoS One; 2014; 9(5):e96370. PubMed ID: 24823794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.